Codexis, Inc.

CDXS Healthcare Biotechnology

Codexis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.4 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 2.69%, EPS grew 18.8%, free cash flow grew 48.6% and total debt fell 14.1%, each against the same quarter a year earlier.

1.25 0.11 −8.09%
Market cap
$148.9M
P/E
0.0×
Fwd P/E
−6.6×
Dividend yield
—
F-score
4/9
Altman Z
−4.75
Beneish M
−3.57
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
3 2 4 2 3 3 4 3 3 4
P/S ratio
3.74 7.53 14.39 13.20 18.76 19.27 2.20 3.03 5.90 2.02
Altman Z-Score
(3.62) (0.29) 17.98 10.21 13.59 13.32 0.01 (3.23) (3.02) (4.75)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 101.52 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(24.38) (18.69) (7.83) (1.16) 2.07 (0.22) (2.00) (10.64) (10.79) (11.56)
Beneish M-Score
(3.52) (2.86) (2.07) (1.64) (2.44) (1.91) (3.12) (4.02) (3.19) (3.57)
P/Operating CF
35.41 49.40 (1,210.87) (246.88) (868.52) 3,059.15 62.06 (19.26) (21.26) 7.07
P/B ratio
9.57 15.35 15.48 8.57 7.62 12.28 2.11 2.45 5.23 2.81
EV/Sales
3.37 6.92 13.51 12.24 16.91 18.57 1.65 2.28 5.14 1.47
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(60.78) (35.56) (48.57) (51.43) (57.76) (69.33) 76.16 (2.84) (5.69) (4.34)
Current Ratio
2.20 1.81 3.77 7.42 7.38 4.85 3.32 2.61 4.18 3.82
Net Debt/EBITDA
4.57 1.39 5.22 8.28 6.63 4.41 3.09 1.13 0.87 1.11
Debt/Equity
0.05 0.03 0.00 0.24 0.13 0.27 0.26 0.00 0.43 0.79
ROE
(40.77%) (105.38%) (26.91%) (14.75%) (17.42%) (12.72%) (21.73%) (65.89%) (85.03%) (74.88%)
ROA
(21.32%) (51.52%) (16.37%) (10.45%) (12.95%) (9.09%) (13.52%) (39.41%) (45.72%) (29.63%)
ROIC
(719.42%) 0.00% (209.91%) (19.95%) (35.88%) (15.66%) (31.79%) (202.78%) (167.23%) (218.36%)
Return on Tangible Assets
(50.30%) (100.41%) (19.83%) (11.36%) (14.20%) (14.20%) (24.62%) (104.26%) (73.08%) (52.03%)
Average Days of Receivables
44.28 86.10 81.12 101.99 130.88 115.31 102.07 99.46 89.24 52.86
Earnings Yield
(4.44%) (6.13%) (1.32%) (1.34%) (1.83%) (1.09%) (10.92%) (35.58%) (18.87%) (31.90%)
Free Cash Flow Yield
(1.48%) (2.58%) (1.93%) (1.80%) (1.56%) (1.39%) 0.99% (26.49%) (15.32%) (16.79%)
Free Cash Flow per Share
(0.07) (0.21) (0.32) (0.29) (0.34) (0.43) 0.05 (0.83) (0.73) (0.27)
Book value per Share
0.47 0.53 1.08 1.87 2.87 2.55 2.22 1.27 0.91 0.58
Free Cash Flow
(2.71) (9.74) (16.86) (16.29) (20.21) (28.06) 3.01 (56.30) (53.63) (23.84)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates